EODData

MEMBERSHIP REGISTER LOG IN

NYSE, GKOS: Glaukos Corp

23 Oct 25 13:25
LAST:

75.41

CHANGE:
 1.22		OPEN:
76.21		HIGH:
77.07		ASK:
41.99		VOLUME:
239.5K
CHG(%):
1.59		PREV:
76.63		LOW:
75.01		BID:
41.98		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Oct 2576.2177.0775.0175.41239.5K
22 Oct 2576.9976.9974.4476.631.69M
21 Oct 2579.5179.7373.7375.883.14M
20 Oct 2588.8089.7575.3679.473.19M
17 Oct 2584.7988.9484.7987.17467.8K
17 Oct 2584.7988.9484.7987.17707.7K
16 Oct 2585.8987.4884.5485.33749.2K
16 Oct 2585.8987.4884.5485.33545.6K
15 Oct 2585.7486.3783.3585.60754.0K
15 Oct 2585.7486.3783.3585.60754.0K

COMPANY PROFILE

Name:Glaukos Corp
About:Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. The company offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. It also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension; iAccess, a precision blade; and iPRIME, a viscoelastic delivery system. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
Sector:Healthcare
Address:One Glaukos Way, Aliso Viejo, CA, United States, 92656
Website:https://www.glaukos.com
CUSIP:377322102
CIK:0001192448
ISIN:US3773221029
FIGI:BBG000WG2LQ1
LEI:5299004JA1LHE21M6T14

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:78.914.6%
MA10:81.658.3%
MA20:82.9810.0%
MA50:86.6014.8%
MA100:91.6221.5%
MA200:102.7136.2%
RSI14:30.17 
WPR14:-100.00 
MTM14:-11.21
ROC14:-0.13 
ATR:4.19 
Week High:89.7519.0%
Week Low:73.732.3%
Month High:89.7519.0%
Month Low:73.7336.2%
Year High:163.71117.1%
Year Low:73.732.3%
Volatility:20.25